A Study to Investigate the Absorption, Distribution, Metabolism, and Excretion of 14C-JNJ-42847922 After a Single Oral Dose of 40 mg in Healthy Subjects
Clinical trial NCT03025022 · COMPLETED
Trial details
- NCT number
- NCT03025022
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-17
- Primary completion
- 2017-02-27
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.